Post job

INOVIO Pharmaceuticals overview

Industry
Biotechnology
Revenue
Headquarters
Employees
262
Founded in
Website
Organization type
Public
Social media
INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.
INOVIO Pharmaceuticals is a well-established company. It was founded way back in 1979. This time-proven company loves to hire graduates from Temple University, with 30.8% of its employees having attended Temple University. Want to explore some other great places to work in Plymouth Meeting, PA? You can check out our full list of Best Companies to Work For in Plymouth Meeting, PA.
Based in Plymouth Meeting, PA, INOVIO Pharmaceuticals is a medium-sized health care company with 262 employees and a revenue of $217,756.

INOVIO Pharmaceuticals's mission statement

Transforming medicine through the development of synthetic immunotherapies.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

INOVIO Pharmaceuticals employee reviews

Be the first to review!

Do you work at INOVIO Pharmaceuticals?

Help job seekers learn about working at INOVIO Pharmaceuticals

Job openings at INOVIO Pharmaceuticals
10 positions

On this page

Be the first to review INOVIO Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at INOVIO Pharmaceuticals?

The team at INOVIO Pharmaceuticals

  • The founders of INOVIO Pharmaceuticals are David B. Weiner and J. Joseph Kim.
  • The key people at INOVIO Pharmaceuticals are David B. Weiner and J. Joseph Kim.
Key people
David B. Weiner
J. Joseph Kim

INOVIO Pharmaceuticals rankings

INOVIO Pharmaceuticals is ranked #7 on the Best Health Care companies to work for in Plymouth Meeting, PA list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

INOVIO Pharmaceuticals salaries

Average INOVIO Pharmaceuticals salary
$89,136
yearly
$42.85 hourly
Updated March 14, 2024

Rate INOVIO Pharmaceuticals' promotion and raise policies.

Zippia waving zebra

INOVIO Pharmaceuticals diversity

6.9
Diversity score
We calculated INOVIO Pharmaceuticals’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of INOVIO Pharmaceuticals’s workforce.
INOVIO Pharmaceuticals diversity summary. Zippia estimates INOVIO Pharmaceuticals's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated INOVIO Pharmaceuticals's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of INOVIO Pharmaceuticals's workforce.
  • INOVIO Pharmaceuticals has 262 employees.
  • 41% of INOVIO Pharmaceuticals employees are women, while 59% are men.
  • The most common ethnicity at INOVIO Pharmaceuticals is White (47%).
  • 27% of INOVIO Pharmaceuticals employees are Asian.
  • 15% of INOVIO Pharmaceuticals employees are Hispanic or Latino.
  • The average employee at INOVIO Pharmaceuticals makes $89,136 per year.
  • Employees at INOVIO Pharmaceuticals stay with the company for 2.6 years on average.

Do you work at INOVIO Pharmaceuticals?

Were you satisfied with INOVIO Pharmaceuticals' salary and benefits?

INOVIO Pharmaceuticals financial performance

4.7
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

INOVIO Pharmaceuticals currently has 10.3M in revenue. INOVIO Pharmaceuticals's most recent quarter produced 226.0k (q2'2023).

INOVIO Pharmaceuticals annual revenue

$42M
$34M
$25M
$17M
$8M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at INOVIO Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

INOVIO Pharmaceuticals FAQs

Search for jobs

Zippia gives an in-depth look into the details of INOVIO Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about INOVIO Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at INOVIO Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by INOVIO Pharmaceuticals. The data presented on this page does not represent the view of INOVIO Pharmaceuticals and its employees or that of Zippia.

INOVIO Pharmaceuticals may also be known as or be related to INOVIO PHARMACEUTICALS, INC., INOVIO Pharmaceuticals, Inovio Pharmaceuticals, Inovio Pharmaceuticals Inc and Inovio Pharmaceuticals, Inc.